The Architecture of Consolidation: Nests of Corporate Control in the Agrochemical Network
ABSTRACT Research on agricultural consolidation tends to equate corporate control with the dominance of a few large firms. We take an alternative approach that examines control through the explosive growth of legally distinct firms that fragment accountability. Using a new global dataset of 6982 entities linked to BASF, Bayer, Corteva, Dow, DuPont, FMC,
Loka Ashwood +5 more
wiley +1 more source
Molecular Feasibility of Gene Sequencing on Lymph Node Fine-Needle Cytology Samples of Non-Hodgkin Lymphoma. [PDF]
D'Ardia A +9 more
europepmc +1 more source
Abstract Orthotopic allograft transplantation (OAT) is a significant approach to addressing organ failure. However, persistent immune responses to the allograft affect chronic rejection, which induces OAT vasculopathy (OATV) and organ failure. Porphyromonas gingivalis can infiltrate remote organs via the bloodstream, thereby intensifying the severity ...
Chien‐Sung Tsai +7 more
wiley +1 more source
Adverse event reporting patterns of rituximab and obinutuzumab in B-cell non-Hodgkin lymphoma: a FAERS pharmacovigilance study. [PDF]
Ma W, Fu H, Zhou Y, Wu Y.
europepmc +1 more source
Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups. [PDF]
Medina-Gil D +14 more
europepmc +1 more source
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez +16 more
wiley +1 more source
Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma. [PDF]
Shirouchi Y +9 more
europepmc +1 more source
Case Report of a Rapidly Progressive Indolent T‐Cell Lymphoma of the Gastrointestinal Tract
ABSTRACT Indolent T‐cell lymphoma of the gastrointestinal tract (iTCL‐GI) is a relatively newly recognized disease entity. iTCL‐GI was first proposed by Perry et al. in 2013, before it was formally incorporated as a distinct disease category in the fifth edition of the World Health Organization Classification of Hematolymphoid Tumors: Lymphoid ...
Keitaro Shibuya +9 more
wiley +1 more source
Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study. [PDF]
Thrun MC +7 more
europepmc +1 more source
Global trends in the burden of non-Hodgkin Lymphoma: a comprehensive analysis from 1990 to 2045. [PDF]
Wang S, Wang J, Lin J.
europepmc +1 more source

